NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…
Opening plenary session features latest fetal fraction amplification researchSALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
NASHVILLE, Tenn., Jan. 28, 2025 /PRNewswire/ -- The Women's Health research Collaborative (WHrC), a Petauri Kinect network of excellence, and…
Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planningNEW YORK,…
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with…
Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY, Jan. 27, 2025…
Conference call and webcast scheduled to take place on Wednesday, February 5, 2025, at 4:30 p.m. E.T.SCOTTSDALE, Ariz., Jan. 23,…
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
REYKJAVIK, Iceland, Jan. 22, 2025 /PRNewswire/ -- Complete recombination map of the human-genome, a major step in genetics Scientists at…
PROVIDENCE, R.I., Jan. 22, 2025 /PRNewswire/ -- ParentData, the data-driven guide through pregnancy, parenthood, and beyond, has announced the relaunch of…